Tetrodotoxin Open-label Efficacy and Safety Continuation Study
Clinical trial NCT00726011 · COMPLETED
Trial details
- NCT number
- NCT00726011
- Sponsor
- Wex Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2011-12-01
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.